142 related articles for article (PubMed ID: 3036380)
1. Wilms' tumor: prognostic factors and survival.
Yildiz I; Ulukutlu L; Büyükünal C; Ober A; Aksoy F; Yeker D; Uzel R; Danişmend N; Okkan S; Oz F
Chemioterapia; 1987 Apr; 6(2):140-3. PubMed ID: 3036380
[TBL] [Abstract][Full Text] [Related]
2. [Wilms' tumor. Its multidisciplinary management].
Rivera Luna R; Martínez Guerra G; Ruano Aguilar J; Cárdenas Cardoz R; Lanche Guevara T
Gac Med Mex; 1992; 128(2):97-104; discussion 104-5. PubMed ID: 1338780
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
4. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
5. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
[TBL] [Abstract][Full Text] [Related]
7. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
8. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumour: treatment of 113 patients from 1960 to 1971.
Jenkin RD; Darte JM; Jeffs RD; Stephens CA; Sonley MJ
Can Med Assoc J; 1975 Feb; 112(3):308-13. PubMed ID: 162847
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Wilms' tumor (author's transl)].
Pichler E; Jürgenssen OA; Reinartz G; Kärcher KH; Helmer F; Esch W; Krepler R; Urban C; Kurz R; Sauer H; Hubmer G; Hackl A; Kahr E; Kaulfersch W; Haas H; Menardi G; Hüttenberger J; Krepler P; Flamm C; Wurnig P; Rosenkranz A; Busch U; Messner H; Brandesky G; Mutz I; Tulzer W; Hartl H; Howanietz L; Rücker J
Dtsch Med Wochenschr; 1981 Sep; 106(39):1248-53. PubMed ID: 6282555
[TBL] [Abstract][Full Text] [Related]
12. [Wilms' tumor. Clinico-prognostic correlates].
Castel V; Ferris J; García-Ballesteros JV; Verdeguer A; García-Hernández A; García-Ibarra F; Minguell J
An Esp Pediatr; 1983 Nov; 19(5):371-8. PubMed ID: 6318620
[TBL] [Abstract][Full Text] [Related]
13. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
[TBL] [Abstract][Full Text] [Related]
14. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor: evaluation of histological features.
Takaoka S
Bull Tokyo Med Dent Univ; 1977 Mar; 24(1):27-42. PubMed ID: 192480
[TBL] [Abstract][Full Text] [Related]
16. [The assessment of nephroblastoma therapy results using the SIOP 92-01 protocol].
Madziara W; Bohosiewicz J
Wiad Lek; 1998; 51 Suppl 3():106-9. PubMed ID: 9814117
[TBL] [Abstract][Full Text] [Related]
17. The treatment of stages I-IV favorable histology Wilms' tumor.
Green DM
J Clin Oncol; 2004 Apr; 22(8):1366-72. PubMed ID: 15084612
[No Abstract] [Full Text] [Related]
18. Adult Wilms' tumor: A monoinstitutional experience and a review of the literature.
Terenziani M; Spreafico F; Collini P; Piva L; Perotti D; Podda M; Gandola L; Massimino M; Cereda S; Cefalo G; Luksch R; Casanova M; Ferrari A; Polastri D; Valagussa P; Fossati-Bellani F
Cancer; 2004 Jul; 101(2):289-93. PubMed ID: 15241825
[TBL] [Abstract][Full Text] [Related]
19. Postoperative chemotherapy in the National Wilms' Tumor Studies.
Levien MG; Bringelsen KA
Semin Urol Oncol; 1999 Feb; 17(1):40-5. PubMed ID: 10073405
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor: histologic grading as a prognostic factor in tumors beyond 10cm in diameter.
Pow-Sang J; Ramírez G; Benavente V
Prog Clin Biol Res; 1982; 100():145-54. PubMed ID: 6292927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
